Akzo Nobel NV AKZO NOBEL ORD SHS/ NL0013267909 /
24/05/2024 18:18:03 | Chg. - | Volume | Bid17:40:12 | Ask17:40:12 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
64.46EUR | - | 634,519 Turnover: 1.65 mill. |
-Bid Size: - | -Ask Size: - | 10.74 bill.EUR | 3.14% | 24.04 |
GlobeNewswire
27/08
Focused on Youth, Forward for Future: the 2024 WLA Forum Sustains to Support the Development of Yout...
GlobeNewswire
19/08
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Inv...
GlobeNewswire
19/08
Qubit Pharmaceuticals nominated for "Best start-up" award at Prix Galien USA 2024
GlobeNewswire
13/08
Alliance for Decision Education Announces Grant to Advance Decision-Making Research
GlobeNewswire
12/08
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman
GlobeNewswire
12/08
4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire
09/08
Ushering in a New Phase: E China's Wuxi Hosts 2024 Taihu Talent Development Conference
GlobeNewswire
08/08
Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference
GlobeNewswire
07/08
Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer
GlobeNewswire
06/08
Pattern CEO Joins Nobelists and Global Leaders Looking Toward the Next Decade in the International R...
GlobeNewswire
24/07
Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast
GlobeNewswire
17/07
4DMT Announces Positive Phase 2 PRISM Interim Results for Intravitreal 4D-150 in a Broad Wet AMD Pop...